EMD Millipore has announced two new collaborations this week focused on vaccine bioengineering and stem cell media.
The US FDA has published a 483 detailing the violations it observed during an inspection of stem cell firm Celltex Therapeutics in April and the document does not make for comfortable reading.
BGI has joined with GE Healthcare in a multi-year push to advance stem cell-derived assays for drug discovery and toxicology.
New Hamner - PBM venture says its toxicity testing could save billions in drug discovery
The Hamner Institutes for Health Sciences and private equity firm PBM Capital Group (PBM) have thrashed out a venture for toxicity testing which they say could save the drug discovery industry billions.
Lonza inks stem cell production pact with Mesoblast
Lonza may build a stem cell production facility dedicated to manufacturing Mesoblast products after inking an alliance.
Cellcura signs HSA-free media deal with IDT for vacc development
CellCura has inked an agreement with IDT Biologika for the testing and adaptation of its protein-free (PF) media for the production of cell lines for vaccine manufacturing.
apceth gets the go-ahead for somatic cell line production
Contract manufacturing of somatic cell line therapies is to begin at apceth after the German company received a license.
Angel calls in local engineering firm to re-commission plant
CMO Angel Biotechnologies has called in UK-based engineering group WH Partnership to help re-commissioning its GMP standard biomanufacturing facility in Cramlington near Newcastle-upon-Tyne.
Angel providing GMP stem cell production to ReNeuron
ReNeuron has inked a new deal with Angel Biotechnology to outsource stem cell GMP production services to the CMO.
Planning key to cell therapies' $6bn growth
Planning the commercial production and delivery of effective cell therapies will be key if the sector is to achieve forecast growth of $6bn within nine years, according to a seminar at the InterPhex trade event in New York City.
Cali bioproduction set to grow but education must improve
Californian bioproduction expansions could create jobs in 2011 but changes to education are needed to sustain growth, according to a survey.
CIT joins “ScreenTox” stem cell development project
French contract research organisation (CRO) CIT will work on in vitro toxicity testing for pharmaceutical and cosmetic ingredients as the newest member of the European “ScreenTox” network.
Beta-Pro expands facilities to break into $2bn hepatocyte market
Beta-Pro is addressing rising demands from drug discovery and research institutes in the hepatocyte market by expanding its site at the University of Virginia Research Park, US, with a new GLP facility.
Stemedica & AnC form stem cell production joint venture
Stemedica and AnC Bio have formed a joint venture to manufacture stem cells for the treatment of ischemic stroke and other degenerative disorders.
NeoStem’s cGMP approval finds favour with investors
Suzhou Erye, a subsidiary of NeoStem Pharmaceutical, has passed inspection by the Chinese Food and Drug Administration (SFDA) meaning the company's new manufacturing facility will go ahead with the manufacture of penicillin and cephalosporin powder...
Beike opens China stem cell storage and processing site
Beike Biotechnology has opened a stem cell storage and processing facility at the 20,000 sq m regenerative medicine base in China, furthering the nation’s development in the field.
Synthemax cuts hESC production cost say Geron and Corning
New Synthemax synthetic growth matrix promises improved scalability for large-scale hESC production which, say developers Geron and Corning, will cut cost of cell therapy manufacture.
ISCO stem cell production site passes building inspection
ISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the processes and cGMP standards needed to produce clinical-grade products.
CMO Angel signs stem cell production deal
Angel Biotechnology has inked a deal to manufacture the CTX stem cell line, which can now be frozen and thawed when needed, at its dedicated cell-based therapies plant that is equipped and licensed for the task.
Cali OKs Stemedica to manufacture stem cells for trials
Stemedica Cell Technologies’ new license to make stem cells for trials positions the firm as a “valuable resource for front line researchers,” according to VP of business development Dave McGuigan.
Downstream demand helps Millipore’s Q2
Demand for downstream processing products from biotechs drove the continued recovery of Millipore’s bioprocessing division in Q2 but operating income remained flat.
Pfizer’s stem cell unit and UCL focus on eye disorders
Pfizer’s development deal with stem-cell researchers at University College of London’s (UCL) Institute of Opthalmology, aimed at reversing vision loss in AMD, has drawn a great deal of interest from investors and the drug industry alike.
China ramps up stem cell efforts just weeks after US research U-turn
Construction of a new stem cell research and processing plant began yesterday in China’s Eastern Jiangsu province as part of a joint project between the Chinese government and Shenzen Beike Biotechnology.
SCS welcomes StemCells deal in light of US rule change
Alastair Riddell, CEO of UK firm Stem Cell Sciences (SCS), says the US governments’ reversal of the ban on federally funded stem cell research “opens up a market that was inhibited, restrained and impeded under the Bush administration.”
Obama overturns stem cell research funding ban
The US green light for federally funded embryonic stem cell research is being hailed as a victory by the US drug industry, which predicts it will open the flood gates for novel medications and help revitalise the sector.
First green light for stem cell clinical trials
The US Food and Drug Administration (FDA) gave the go-ahead to the first clinical trials of a stem cell-based therapy late last week, in a major boost to the development of the technology.
ReInnervate the difference for stem cells
UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
New research takes the bite out of the stem cell debate
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
New well plate differentiates itself from the crowd
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
NJ and the shifting landscape of pharma employment
People employed in the pharmaceutical industry in New Jersey, USA fell by one per cent in 2007, according to a report by the HealthCare Institute of New Jersey (HINJ).
Millipore tech unravels neural degeneration
UK researchers have used the ReNcell VM stem cell line, licensed by Millipore from UK stem cell therapy experts ReNeuron, to model neural degeneration observed in Parkinson's disease.
Nanopoint images the future of live cell experiments
Nanopoint has launched the 'world's most advanced' on-microscope cell containment device that offers complete environmental control for time-lapse cell imaging applications.
PerkinElmer forms stem cell research centre
PerkinElmer has created the ViaCord Research Institute (VRI) to
investigate new uses of stem cells derived from umbilical cord
Pharmaceutical excipients roundup
In-PharmaTechnologist's periodic round-up of events in the
pharmaceutical excipient space includes one product launch and two
Big pharma enters stem cell domain to address safety, attrition
Three of the world's biggest pharmaceutical companies have signed a
landmark deal with the UK government that will see them use stem
cell technology to road-test the safety of new compounds.
New US player in contract assay services field
The burgeoning US contract assay services arena has witnessed the
arrival of a brand new player with the launch of ReachBio, which is
opening its business operations this week.
Invitrogen takes the stress out of stem cell 'passaging'
The launch of Invitrogen's Stempro EZPassage should substantially
reduce the time and stress involved in dividing up cultures of
human embryonic stem cell (hESC) colonies.
ReNeuron awarded EU stem cell patents
The European Union Patent Office (EPO) has granted UK stem cell
experts ReNeuron patent protection for three key human neural
stem cell lines.
A new study has shown that certain human bone marrow stem cells can differentiate into sperm stem cells - potentially leading to a revolution in fertility therapy.
Baxter to increase research spending
Baxter has pledged to invest a greater proportion of its profit in
R&D, to bring the company in line with other pharma firms.
Millipore licenses neural stem cells
A new licensing deal will allow Millipore to supply researchers
with a commercial source of neural stem cells for the first time.
Patenting stem cells is 'ethical'
A recent article published in the journal Stem Cell has advocated
the patenting of isolated stem cell lines.
Contract manufacturing news in brief
Dalton Pharma Services, Granules India and Lonza have all announced
new contract manufacturing deals this week.
Robotics could speed up stem cell research
Scientists hope to speed up the development of regenerative drugs
for diseases such as cancer by using robotics to automate stem cell
Cellartis channels Scottish expertise in stem cells
Cellartis has begun a new research programme in Scotland as part of
a £9.5m (€14.5m) programme by ITI Life Sciences to develop the
world's first automated process to produce high-quality human stem
ReNeuron 'confident' in stem cell therapy, despite delay
ReNeuron remains confident that its new stem cell therapy for
stroke will be approved to start clinical trials, despite a request
for further information from the industry regulator.
UK chimeric stem cell research in the balance
The UK's Human Fertilisation and Embryology Authority (HFEA) has
called for a public consultation into the use of animal eggs to
create cloned hybrid or chimeric human embryos for laboratory-based
Stem cell device could have role in cancer treatment
Researchers at the University of Rochester and StemCapture have
unveiled a new device technology that makes it possible to harvest
stem cells from the blood, bypassing the controversial use of stem
cells sourced from embryos.
Ethical Stem Cell Source
Scientists have discovered stem cells in the amniotic fluid that
surrounds the foetus in pregnant women, bypassing ethical concerns
over the source of the versatile cells.
PACS stem cell purifier
New stem cell purification technology allows fast and accurate